Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Richard A Gonzalez. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Richard A Gonzalez har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ABBV / AbbVie Inc. | Director | 386 479 |
US:ABT / Abbott Laboratories | Executive Vice President | 49 432 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Richard A Gonzalez. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Richard A Gonzalez som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −2 450 | 386 479 | −0,63 | ||||
2025-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −6 168 | 388 929 | −1,56 | 210,53 | −1 298 549 | 81 881 222 | |
2025-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −92 460 | 395 097 | −18,96 | 205,11 | −18 964 471 | 81 038 346 | |
2025-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −73 209 | 487 557 | −13,06 | 205,02 | −15 009 309 | 99 958 936 | |
2025-02-18 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 27 386 | 560 766 | 5,13 | ||||
2025-02-18 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 30 298 | 533 380 | 6,02 | ||||
2025-02-18 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 33 208 | 503 082 | 7,07 | ||||
2025-02-18 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 80 945 | 469 874 | 20,81 | ||||
2024-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −36 698 | 388 929 | −8,62 | ||||
2024-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −15 729 | 425 627 | −3,56 | ||||
2024-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −5 243 | 441 356 | −1,17 | ||||
2024-08-07 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −66 500 | 446 599 | −12,96 | 186,52 | −12 403 580 | 83 299 645 | |
2024-07-19 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −282 845 | 513 099 | −35,54 | 175,00 | −49 497 875 | 89 792 325 | |
2024-07-19 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 76 377 | 795 944 | 10,61 | 93,50 | 7 141 250 | 74 420 764 | |
2024-07-19 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 119 418 | 719 567 | 19,90 | 79,02 | 9 436 410 | 56 860 184 | |
2024-07-19 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 87 050 | 600 149 | 16,97 | 61,36 | 5 341 388 | 36 825 143 | |
2024-07-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −6 000 | 513 099 | −1,16 | ||||
2024-03-01 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −138 616 | 519 099 | −21,08 | 177,27 | −24 572 458 | 92 020 680 | |
2024-03-01 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −110 249 | 657 715 | −14,36 | 178,99 | −19 733 469 | 117 724 408 | |
2024-02-29 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −2 525 | 767 964 | −0,33 | ||||
2024-02-29 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −1 670 | 770 489 | −0,22 | ||||
2024-02-20 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 30 300 | 772 159 | 4,08 | ||||
2024-02-20 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 33 208 | 741 859 | 4,69 | ||||
2024-02-20 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 39 022 | 708 651 | 5,83 | ||||
2024-02-20 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 146 335 | 669 629 | 27,96 | ||||
2023-09-27 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −42 000 | 523 294 | −7,43 | ||||
2023-08-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −60 000 | 565 294 | −9,60 | 148,58 | −8 914 800 | 83 991 383 | |
2023-08-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −18 500 | 625 294 | −2,87 | 149,15 | −2 759 275 | 93 262 600 | |
2023-03-07 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −2 550 | 643 794 | −0,39 | ||||
2023-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −113 810 | 646 344 | −14,97 | 154,28 | −17 558 607 | 99 717 952 | |
2023-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 33 210 | 760 154 | 4,57 | ||||
2023-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 39 022 | 726 944 | 5,67 | ||||
2023-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 34 937 | 687 922 | 5,35 | ||||
2023-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 149 732 | 652 985 | 29,75 | ||||
2022-03-01 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −102 812 | 503 253 | −16,96 | 149,54 | −15 374 506 | 75 256 454 | |
2022-03-01 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −2 610 | 606 065 | −0,43 | ||||
2022-02-22 |
|
4 | ABBV |
AbbVie Inc.
Option (Right To Buy) |
A - Award | 157 618 | 157 618 | |||||
2022-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 34 146 | 608 675 | 5,94 | ||||
2022-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 34 937 | 574 529 | 6,47 | ||||
2022-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 29 106 | 539 592 | 5,70 | ||||
2022-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 133 889 | 510 486 | 35,55 | ||||
2021-12-10 |
|
4 | ABBV |
AbbVie Inc.
Option (Right To Buy) |
M - Exercise | −174 100 | 87 050 | −66,67 | 61,36 | −10 682 776 | 5 341 388 | |
2021-12-10 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −109 624 | 376 597 | −22,55 | 123,48 | −13 535 911 | 46 500 616 | |
2021-12-10 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −64 476 | 486 221 | −11,71 | 122,80 | −7 917 730 | 59 708 522 | |
2021-12-10 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 174 100 | 550 697 | 46,23 | 61,36 | 10 682 776 | 33 790 768 | |
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Option (Right To Buy) |
M - Exercise | −170 113 | 0 | −100,00 | 54,86 | −9 332 399 | ||
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 170 113 | 546 710 | 45,17 | 54,86 | 9 332 399 | 29 992 511 | |
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −631 | 376 597 | −0,17 | 109,32 | −68 984 | 41 171 467 | |
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −169 482 | 377 228 | −31,00 | 108,61 | −18 407 220 | 40 970 243 | |
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −74 384 | 376 597 | −16,49 | 107,74 | −8 014 132 | 40 574 561 | |
2021-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −3 325 | 450 981 | −0,73 | ||||
2021-02-22 |
|
4 | ABBV |
AbbVie Inc.
Option (Right To Buy) |
A - Award | 192 546 | 192 546 | |||||
2021-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 34 938 | 454 306 | 8,33 | ||||
2021-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 29 106 | 419 368 | 7,46 | ||||
2021-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 23 605 | 390 262 | 6,44 | ||||
2021-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 80 257 | 366 657 | 28,02 | ||||
2020-12-31 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −29 017 | 286 400 | −9,20 | ||||
2020-12-11 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −3 225 | 315 417 | −1,01 | ||||
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Option(Right to buy) |
M - Exercise | −109 097 | 0 | −100,00 | ||||
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Option(Right to buy) |
M - Exercise | −85 057 | 170 113 | −33,33 | ||||
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −16 171 | 318 642 | −4,83 | 97,49 | −1 576 493 | 31 064 058 | |
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −177 983 | 334 813 | −34,71 | 97,06 | −17 275 297 | 32 497 452 | |
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 109 097 | 512 796 | 27,02 | 58,88 | 6 423 631 | 30 193 428 | |
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
M - Exercise | 85 057 | 403 699 | 26,69 | 54,86 | 4 666 227 | 22 146 927 | |
2020-11-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −37 450 | 318 642 | −10,52 | 95,74 | −3 585 463 | 30 506 785 | |
2020-05-12 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | 5 450 | 5 900 | 1 211,11 | ||||
2020-05-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | 5 450 | 5 900 | 1 211,11 | ||||
2020-05-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | 10 900 | 17 615 | 162,32 | ||||
2020-05-12 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −21 800 | 356 092 | −5,77 | ||||
2020-04-02 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −56 950 | 377 892 | −13,10 | ||||
2020-03-03 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
F - Taxes | −88 719 | 434 842 | −16,95 | 85,42 | −7 578 377 | 37 144 204 | |
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −3 675 | 523 561 | −0,70 | ||||
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 229 132 | 229 132 | |||||
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 29 107 | 527 236 | 5,84 | ||||
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 23 604 | 498 129 | 4,97 | ||||
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 39 109 | 474 525 | 8,98 | ||||
2020-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
A - Award | 108 442 | 435 416 | 33,17 | ||||
2019-12-13 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −4 000 | 326 974 | −1,21 | ||||
2019-09-11 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −15 010 | 335 155 | −4,29 | ||||
2019-08-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −3 050 | 350 165 | −0,86 | ||||
2019-08-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −15 333 | 353 215 | −4,16 | ||||
2019-08-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −6 375 | 368 548 | −1,70 | ||||
2019-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −72 925 | 374 923 | −16,28 | 79,41 | −5 790 974 | 29 772 635 | |
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 179 127 | 179 127 | |||||
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 23 605 | 450 812 | 5,53 | ||||
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 39 109 | 427 207 | 10,08 | ||||
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 42 649 | 388 098 | 12,35 | ||||
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 59 246 | 345 449 | 20,70 | ||||
2019-02-22 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −2 964 | 447 848 | −0,66 | ||||
2018-12-13 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
S - Sale | −16 850 | 286 203 | −5,56 | 88,75 | −1 495 438 | 25 400 516 | |
2018-11-30 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −4 237 | 303 053 | −1,38 | ||||
2018-04-13 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | 2 115 | 6 715 | 45,98 | ||||
2018-04-13 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −5 722 | 307 290 | −1,83 | ||||
2018-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −8 280 | 313 012 | −2,58 | 117,88 | −976 084 | 36 899 263 | |
2018-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −79 491 | 321 292 | −19,83 | 118,26 | −9 400 606 | 37 995 992 | |
2018-02-16 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 127 610 | 127 610 | |||||
2018-02-16 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 39 111 | 400 783 | 10,81 | ||||
2018-02-16 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 45 186 | 361 672 | 14,28 | ||||
2018-02-16 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 42 649 | 316 486 | 15,57 | ||||
2017-11-24 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −218 193 | 109 097 | −66,67 | ||||
2017-11-24 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −218 193 | 273 837 | −44,35 | 94,01 | −20 511 800 | 25 742 759 | |
2017-11-24 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 218 193 | 492 030 | 79,68 | 58,88 | 12 847 204 | 28 970 726 | |
2017-11-13 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | 2 655 | 273 837 | 0,98 | ||||
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −193 131 | 0 | −100,00 | ||||
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 200 | 276 492 | −0,43 | 71,03 | −85 236 | 19 639 227 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −9 618 | 277 692 | −3,35 | 71,01 | −682 974 | 19 718 909 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −446 | 287 310 | −0,15 | 71,04 | −31 682 | 20 409 066 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 158 | 287 756 | −1,09 | 71,02 | −224 281 | 20 436 431 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 602 | 290 914 | −0,89 | 71,04 | −184 846 | 20 666 531 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 100 | 293 516 | −0,37 | 71,04 | −78 150 | 20 852 844 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −157 163 | 294 616 | −34,79 | 71,00 | −11 158 573 | 20 917 736 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 800 | 451 779 | −0,40 | 71,06 | −127 908 | 32 103 416 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 153 | 453 579 | −0,25 | 71,02 | −81 880 | 32 210 913 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −6 200 | 454 732 | −1,35 | 71,05 | −440 510 | 32 308 709 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 | 460 932 | 0,00 | 71,06 | −213 | 32 756 133 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 460 935 | −0,02 | 71,06 | −7 106 | 32 751 736 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 809 | 461 035 | −0,39 | 71,02 | −128 484 | 32 745 011 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −6 779 | 462 844 | −1,44 | 71,00 | −481 343 | 32 864 238 | |
2017-08-08 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 193 131 | 469 623 | 69,85 | 51,42 | 9 930 796 | 24 148 015 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −22 038 | 193 131 | −10,24 | ||||
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −737 | 276 492 | −0,27 | 71,13 | −52 423 | 19 666 876 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 277 229 | −0,07 | 71,11 | −14 222 | 19 713 754 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 277 429 | −0,18 | 71,10 | −35 552 | 19 726 589 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 900 | 277 929 | −0,68 | 71,08 | −135 052 | 19 755 193 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 000 | 279 829 | −1,06 | 71,07 | −213 210 | 19 887 447 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −15 600 | 282 829 | −5,23 | 71,06 | −1 108 536 | 20 097 829 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −101 | 298 429 | −0,03 | 71,00 | −7 171 | 21 188 459 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 22 038 | 364 391 | 6,44 | 51,42 | 1 133 194 | 18 736 985 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −65 861 | 215 169 | −23,44 | ||||
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −35 | 298 530 | −0,01 | 71,00 | −2 485 | 21 197 123 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −65 826 | 298 565 | −18,06 | 71,00 | −4 673 646 | 21 198 115 | |
2017-08-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 65 861 | 342 353 | 23,82 | 51,42 | 3 386 573 | 17 603 791 | |
2017-06-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −2 235 | 276 492 | −0,80 | ||||
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 100 | 278 727 | −0,39 | 65,52 | −72 066 | 18 260 799 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 279 827 | −0,46 | 65,51 | −85 163 | 18 331 467 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −700 | 281 127 | −0,25 | 65,51 | −45 855 | 18 415 927 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −30 549 | 281 827 | −9,78 | 65,50 | −2 001 112 | 18 461 078 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 312 376 | −0,06 | 65,50 | −13 100 | 20 460 628 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 600 | 312 576 | −0,51 | 65,50 | −104 792 | 20 472 165 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 314 176 | −0,25 | 65,49 | −52 392 | 20 575 386 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −8 175 | 314 976 | −2,53 | 65,48 | −535 340 | 20 626 203 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 323 151 | −0,19 | 65,48 | −39 288 | 21 159 927 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −8 100 | 323 751 | −2,44 | 65,48 | −530 348 | 21 197 597 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 400 | 331 851 | −0,42 | 65,47 | −91 658 | 21 726 285 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −14 011 | 333 251 | −4,03 | 65,46 | −917 230 | 21 816 277 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −700 | 347 262 | −0,20 | 65,46 | −45 822 | 22 731 771 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 347 962 | −0,17 | 65,46 | −39 273 | 22 775 853 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 348 562 | −0,17 | 65,45 | −39 270 | 22 813 383 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 349 162 | −0,09 | 65,44 | −19 634 | 22 850 907 | |
2017-05-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 349 462 | −0,14 | 65,44 | −32 720 | 22 868 793 | |
2017-05-09 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −4 181 | 345 781 | −1,19 | ||||
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −785 | 349 962 | −0,22 | ||||
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −53 650 | 0 | −100,00 | ||||
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −18 366 | 0 | −100,00 | ||||
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −72 016 | 350 747 | −17,03 | 64,25 | −4 627 028 | 22 535 495 | |
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 53 650 | 422 763 | 14,53 | 29,23 | 1 568 002 | 12 355 883 | |
2017-03-10 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 18 366 | 369 113 | 5,24 | 24,21 | 444 608 | 8 935 561 | |
2017-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −112 867 | 350 747 | −24,35 | 62,22 | −7 022 585 | 21 823 478 | |
2017-02-21 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 261 150 | 261 150 | |||||
2017-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 42 651 | 463 614 | 10,13 | ||||
2017-02-21 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 94 797 | 420 963 | 29,06 | ||||
2017-02-03 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −8 415 | 326 166 | −2,52 | ||||
2016-12-09 |
|
4 | ABBV |
AbbVie Inc.
Common Stock, $0.01 par value |
G - Gift | −3 840 | 334 581 | −1,13 | ||||
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Option(right to buy) |
M - Exercise | −285 953 | 0 | −100,00 | ||||
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 700 | 338 421 | −0,50 | 63,92 | −108 656 | 21 630 178 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −7 717 | 340 121 | −2,22 | 63,84 | −492 653 | 21 713 325 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −700 | 347 838 | −0,20 | 63,90 | −44 734 | 22 228 587 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 019 | 348 538 | −0,58 | 63,92 | −129 054 | 22 278 549 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −5 699 | 350 557 | −1,60 | 63,87 | −363 995 | 22 390 076 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 356 256 | −0,17 | 63,92 | −38 355 | 22 773 665 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 400 | 356 856 | −1,22 | 63,91 | −281 204 | 22 806 667 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 300 | 361 256 | −1,18 | 63,86 | −274 598 | 23 069 808 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 365 556 | −0,35 | 63,84 | −82 998 | 23 338 923 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 900 | 366 856 | −1,32 | 63,80 | −312 644 | 23 407 247 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −11 726 | 371 756 | −3,06 | 63,88 | −749 057 | 23 747 773 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 900 | 383 482 | −0,75 | 63,88 | −185 266 | 24 498 748 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 386 382 | −0,10 | 63,84 | −25 534 | 24 664 695 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 511 | 386 782 | −0,39 | 63,85 | −96 477 | 24 696 031 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 388 293 | −0,26 | 63,93 | −63 930 | 24 823 571 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 389 293 | −0,10 | 63,88 | −25 550 | 24 866 090 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −5 397 | 389 693 | −1,37 | 63,83 | −344 491 | 24 874 104 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −13 019 | 395 090 | −3,19 | 63,89 | −831 784 | 25 242 300 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −9 434 | 408 109 | −2,26 | 63,81 | −601 984 | 26 041 435 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 700 | 417 543 | −0,41 | 63,90 | −108 622 | 26 678 910 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 419 243 | −0,07 | 63,81 | −19 142 | 26 750 848 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −5 402 | 419 543 | −1,27 | 63,90 | −345 188 | 26 808 798 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 100 | 424 945 | −0,26 | 63,86 | −70 252 | 27 139 112 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −7 261 | 426 045 | −1,68 | 63,82 | −463 397 | 27 190 192 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −190 468 | 433 306 | −30,53 | 63,80 | −12 151 858 | 27 644 923 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 623 774 | −0,10 | 63,82 | −38 289 | 39 806 138 | |
2016-06-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 285 953 | 624 374 | 84,50 | 35,88 | 10 259 994 | 22 402 539 | |
2016-05-13 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −39 000 | 338 421 | −10,33 | 63,80 | −2 488 200 | 21 591 260 | |
2016-03-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −89 311 | 377 421 | −19,14 | 56,00 | −5 001 416 | 21 135 576 | |
2016-02-22 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 255 170 | 255 170 | |||||
2015-12-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −2 630 | 466 732 | −0,56 | ||||
2015-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −1 475 | 469 362 | −0,31 | ||||
2015-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | 2 350 | 4 600 | 104,44 | ||||
2015-10-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −2 350 | 470 837 | −0,50 | ||||
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −65 000 | 285 953 | −18,52 | ||||
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 513 208 | −0,02 | 71,16 | −7 116 | 36 522 447 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 513 308 | −0,16 | 71,16 | −56 928 | 36 526 997 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 514 108 | −0,10 | 71,16 | −35 578 | 36 581 355 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 514 608 | −0,12 | 71,15 | −42 690 | 36 614 359 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 515 208 | −0,02 | 71,14 | −7 114 | 36 654 473 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 515 308 | −0,10 | 71,14 | −35 570 | 36 659 011 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 515 808 | −0,15 | 71,13 | −56 904 | 36 689 423 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 516 608 | −0,02 | 71,12 | −7 112 | 36 743 744 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 700 | 516 708 | −0,33 | 71,12 | −120 904 | 36 748 273 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 518 408 | −0,04 | 71,12 | −14 223 | 36 866 585 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 997 | 518 608 | −0,38 | 71,11 | −142 007 | 36 878 215 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 520 605 | −0,02 | 71,10 | −7 110 | 37 017 619 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 200 | 520 705 | −0,42 | 71,10 | −156 420 | 37 022 126 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 522 905 | −0,04 | 71,10 | −14 219 | 37 175 931 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 500 | 523 105 | −0,48 | 71,09 | −177 725 | 37 187 534 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 525 605 | −0,02 | 71,08 | −7 108 | 37 362 631 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 800 | 525 705 | −0,53 | 71,08 | −199 024 | 37 367 111 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 528 505 | −0,04 | 71,08 | −14 215 | 37 563 493 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 124 | 528 705 | −0,40 | 71,07 | −150 953 | 37 575 064 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 530 829 | −0,04 | 71,06 | −14 213 | 37 723 363 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 300 | 531 029 | −0,43 | 71,06 | −163 438 | 37 734 921 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 800 | 533 329 | −0,34 | 71,05 | −127 890 | 37 893 025 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 535 129 | −0,02 | 71,04 | −7 104 | 38 018 240 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −700 | 535 229 | −0,13 | 71,04 | −49 728 | 38 022 668 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 535 929 | −0,24 | 71,03 | −92 339 | 38 067 037 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 537 229 | −0,04 | 71,02 | −14 204 | 38 154 004 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −758 | 537 429 | −0,14 | 71,00 | −53 818 | 38 157 459 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 65 000 | 538 187 | 13,74 | 35,88 | 2 332 200 | 19 310 150 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −8 960 | 473 187 | −1,86 | ||||
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 473 187 | −0,11 | 71,34 | −35 670 | 33 757 161 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 200 | 473 687 | −0,25 | 71,33 | −85 596 | 33 788 094 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 474 887 | −0,06 | 71,31 | −21 393 | 33 864 192 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 100 | 475 187 | −0,44 | 71,30 | −149 730 | 33 880 833 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 477 287 | −0,02 | 71,30 | −7 130 | 34 028 177 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −700 | 477 387 | −0,15 | 71,29 | −49 903 | 34 032 919 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 478 087 | −0,21 | 71,28 | −71 280 | 34 078 041 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 400 | 479 087 | −0,29 | 71,27 | −99 778 | 34 144 530 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −350 | 480 487 | −0,07 | 71,26 | −24 943 | 34 241 906 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −11 707 | 480 837 | −2,38 | 71,26 | −834 241 | 34 264 445 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 492 544 | −0,02 | 71,26 | −7 126 | 35 096 223 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 200 | 492 644 | −0,24 | 71,25 | −85 500 | 35 100 885 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 493 844 | −0,02 | 71,24 | −7 124 | 35 183 916 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 936 | 493 944 | −0,39 | 71,24 | −137 921 | 35 188 571 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −5 403 | 495 880 | −1,08 | 71,23 | −384 856 | 35 321 532 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 501 283 | −0,02 | 71,22 | −7 122 | 35 703 882 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 200 | 501 383 | −0,44 | 71,22 | −156 684 | 35 708 497 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 503 583 | −0,02 | 71,22 | −7 122 | 35 863 922 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 503 683 | −0,20 | 71,22 | −71 215 | 35 869 785 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 125 | 504 683 | −0,42 | 71,21 | −151 321 | 35 938 476 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 200 | 506 808 | −0,43 | 71,20 | −156 640 | 36 084 730 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 509 008 | −0,06 | 71,20 | −21 359 | 36 240 097 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 782 | 509 308 | −0,35 | 71,19 | −126 861 | 36 257 637 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 511 090 | −0,06 | 71,18 | −21 356 | 36 381 942 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −818 | 511 390 | −0,16 | 71,18 | −58 225 | 36 400 740 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 512 208 | −0,19 | 71,17 | −71 170 | 36 453 843 | |
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | 450 | 450 | |||||
2015-07-31 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | 2 250 | 2 250 | |||||
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 482 147 | −0,12 | 64,96 | −38 976 | 31 320 269 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 482 747 | −0,06 | 64,95 | −19 485 | 31 354 418 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 483 047 | −0,06 | 64,94 | −19 482 | 31 369 072 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 483 347 | −0,27 | 64,93 | −84 409 | 31 383 721 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 484 647 | −0,06 | 64,92 | −19 476 | 31 463 283 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 484 947 | −0,21 | 64,92 | −64 915 | 31 480 335 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −223 | 485 947 | −0,05 | 64,91 | −14 475 | 31 542 820 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 486 170 | −0,27 | 64,90 | −84 376 | 31 554 864 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 958 | 487 470 | −0,60 | 64,90 | −191 974 | 31 636 803 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 969 | 490 428 | −0,60 | 64,89 | −192 658 | 31 823 873 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 493 397 | −0,04 | 64,88 | −12 976 | 32 012 831 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 800 | 493 597 | −0,36 | 64,88 | −116 784 | 32 024 573 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 000 | 495 397 | −0,20 | 64,88 | −64 875 | 32 138 880 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 497 697 | −0,02 | 64,87 | −6 487 | 32 284 360 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 100 | 497 797 | −0,62 | 64,86 | −201 082 | 32 289 602 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −14 000 | 500 897 | −2,72 | 64,86 | −908 040 | 32 488 179 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 514 897 | −0,16 | 64,86 | −51 886 | 33 394 932 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 869 | 515 697 | −0,36 | 64,86 | −121 214 | 33 445 529 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 517 566 | −0,06 | 64,85 | −19 456 | 33 565 449 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −14 488 | 517 866 | −2,72 | 64,85 | −939 547 | 33 583 610 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 200 | 532 354 | −0,22 | 64,84 | −77 814 | 34 520 495 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 533 554 | −0,07 | 64,84 | −25 937 | 34 596 975 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 100 | 533 954 | −0,39 | 64,84 | −136 164 | 34 621 577 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −600 | 536 054 | −0,11 | 64,84 | −38 901 | 34 755 061 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 900 | 536 654 | −0,72 | 64,83 | −252 837 | 34 791 279 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 500 | 540 554 | −0,46 | 64,82 | −162 050 | 35 038 710 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 400 | 543 054 | −0,26 | 64,82 | −90 741 | 35 198 045 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 544 454 | −0,24 | 64,81 | −84 253 | 35 286 064 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 545 754 | −0,02 | 64,80 | −6 480 | 35 364 859 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 545 854 | −0,05 | 64,79 | −19 437 | 35 365 881 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 546 154 | −0,02 | 64,77 | −6 477 | 35 374 395 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −900 | 546 254 | −0,16 | 64,76 | −58 284 | 35 375 409 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 500 | 547 154 | −0,45 | 64,75 | −161 875 | 35 428 222 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −100 | 549 654 | −0,02 | 64,75 | −6 475 | 35 588 722 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −506 | 549 754 | −0,09 | 64,74 | −32 761 | 35 593 823 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 400 | 550 260 | −0,79 | 64,74 | −284 856 | 35 623 832 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 496 397 | −0,26 | 64,87 | −84 331 | 32 201 273 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
M - Exercise | −175 477 | 350 953 | −33,33 | ||||
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 554 660 | −0,07 | 64,74 | −25 895 | 35 907 302 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −900 | 555 060 | −0,16 | 64,74 | −58 262 | 35 931 809 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 000 | 555 960 | −0,71 | 64,73 | −258 920 | 35 987 291 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 400 | 559 960 | −0,25 | 64,72 | −90 615 | 36 243 411 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 568 354 | −0,05 | 64,72 | −19 414 | 36 781 029 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −8 100 | 568 654 | −1,40 | 64,71 | −524 151 | 36 797 600 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 100 | 576 754 | −0,19 | 64,70 | −71 176 | 37 318 868 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −34 900 | 577 854 | −5,70 | 64,70 | −2 258 030 | 37 387 154 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 612 754 | −0,07 | 64,70 | −25 878 | 39 642 120 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 200 | 613 154 | −0,52 | 64,69 | −207 008 | 39 664 932 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 805 | 616 354 | −0,29 | 64,68 | −116 756 | 39 868 858 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −4 317 | 618 159 | −0,69 | 64,68 | −279 224 | 39 982 524 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 500 | 622 476 | −0,40 | 64,67 | −161 675 | 40 255 523 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 800 | 624 976 | −0,60 | 64,66 | −245 708 | 40 410 948 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −200 | 628 776 | −0,03 | 64,66 | −12 931 | 40 653 512 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −8 100 | 628 976 | −1,27 | 64,65 | −523 665 | 40 663 298 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 000 | 637 076 | −0,47 | 64,64 | −193 920 | 41 180 593 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −900 | 640 076 | −0,14 | 64,62 | −58 158 | 41 361 711 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −3 548 | 640 976 | −0,55 | 64,61 | −229 236 | 41 413 459 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −5 600 | 644 524 | −0,86 | 64,60 | −361 760 | 41 636 250 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 650 124 | −0,12 | 64,59 | −51 672 | 41 991 509 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −300 | 650 924 | −0,05 | 64,58 | −19 374 | 42 036 672 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 300 | 651 224 | −0,20 | 64,57 | −83 941 | 42 049 534 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 100 | 652 524 | −0,32 | 64,56 | −135 576 | 42 126 949 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −400 | 654 624 | −0,06 | 64,53 | −25 812 | 42 242 887 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −800 | 655 024 | −0,12 | 64,52 | −51 616 | 42 262 148 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 800 | 655 824 | −0,27 | 64,50 | −116 100 | 42 300 648 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
M - Exercise | 175 477 | 657 624 | 36,39 | 35,88 | 6 296 115 | 23 595 549 | |
2015-04-30 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −6 994 | 561 360 | −1,23 | 64,72 | −452 652 | 36 331 219 | |
2015-03-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −24 825 | 482 147 | −4,90 | 60,50 | −1 501 912 | 29 169 894 | |
2015-03-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −43 784 | 506 972 | −7,95 | 60,52 | −2 649 808 | 30 681 945 | |
2015-03-03 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −2 400 | 550 756 | −0,43 | ||||
2015-02-23 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 327 290 | 327 290 | |||||
2015-02-23 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 165 590 | 551 918 | 42,86 | ||||
2014-11-26 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −9 075 | 386 328 | −2,30 | ||||
2014-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −500 | 395 403 | −0,13 | 51,21 | −25 607 | 20 250 169 | |
2014-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −2 230 | 395 903 | −0,56 | 51,20 | −114 176 | 20 270 234 | |
2014-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −1 800 | 398 133 | −0,45 | 51,20 | −92 153 | 20 382 817 | |
2014-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
S - Sale | −269 | 399 933 | −0,07 | 51,19 | −13 770 | 20 472 570 | |
2014-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −46 811 | 400 202 | −10,47 | 50,91 | −2 383 148 | 20 374 284 | |
2014-02-24 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 281 030 | 281 030 | |||||
2014-02-24 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 162 960 | 447 013 | 57,37 | ||||
2013-04-05 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −10 | 284 053 | 0,00 | ||||
2013-04-02 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
G - Gift | −12 243 | 284 063 | −4,13 | ||||
2013-03-04 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −7 716 | 296 306 | −2,54 | 36,73 | −283 409 | 10 883 319 | |
2013-02-19 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
F - Taxes | −3 130 | 304 022 | −1,02 | 37,58 | −117 625 | 11 425 147 | |
2013-02-19 |
|
4 | ABBV |
AbbVie Inc.
Option (right to buy) |
A - Award | 526 430 | 526 430 | |||||
2013-02-19 |
|
4 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
A - Award | 257 720 | 307 152 | 521,36 | ||||
2012-12-21 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
G - Gift | −24 982 | 49 432 | −33,57 | ||||
2012-12-07 | 3 | ABBV |
AbbVie Inc.
Common stock, $0.01 par value |
0 | ||||||||
2012-04-10 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −6 909 | 185 575 | −3,59 | 61,30 | −423 522 | 11 375 748 | |
2012-03-02 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −5 417 | 192 484 | −2,74 | 57,04 | −308 986 | 10 979 287 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
M - Exercise | −219 192 | 0 | −100,00 | ||||
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 197 901 | −0,05 | 56,21 | −5 621 | 11 123 817 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −94 | 198 001 | −0,05 | 56,20 | −5 283 | 11 128 646 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −6 172 | 198 095 | −3,02 | 56,20 | −346 866 | 11 132 939 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 204 267 | −0,10 | 56,20 | −11 240 | 11 479 601 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −200 | 204 467 | −0,10 | 56,20 | −11 240 | 11 490 534 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −23 438 | 204 667 | −10,28 | 56,20 | −1 317 098 | 11 501 262 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −5 800 | 228 105 | −2,48 | 56,19 | −325 902 | 12 817 220 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −500 | 233 905 | −0,21 | 56,19 | −28 094 | 13 142 888 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −8 000 | 234 405 | −3,30 | 56,18 | −449 480 | 13 170 045 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −18 389 | 242 405 | −7,05 | 56,18 | −1 033 094 | 13 618 313 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −300 | 260 794 | −0,11 | 56,18 | −16 854 | 14 651 146 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −100 | 261 094 | −0,04 | 56,18 | −5 618 | 14 667 608 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −92 562 | 261 194 | −26,17 | 56,18 | −5 199 670 | 14 672 573 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
S - Sale | −53 071 | 353 756 | −13,05 | 56,17 | −2 980 998 | 19 870 475 | |
2012-02-24 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
M - Exercise | 219 192 | 406 827 | 116,82 | 52,39 | 11 483 469 | 21 313 667 | |
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −5 527 | 187 635 | −2,86 | 56,36 | −311 502 | 10 575 109 | |
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 107 300 | 107 300 | |||||
2012-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 59 400 | 193 162 | 44,41 | ||||
2010-07-02 | 3 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
73 333 | ||||||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
F - Taxes | −6 102 | 290 160 | −2,06 | 44,15 | −269 403 | 12 810 564 | |
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Option (right to buy) |
A - Award | 310 000 | 310 000 | |||||
2006-02-22 |
|
4 | ABT |
ABBOTT LABORATORIES
Common shares without par value |
A - Award | 100 000 | 390 160 | 34,46 | 44,16 | 4 416 000 | 17 229 466 |